Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Zenosense Inc. ZENO
(Total Views: 145)
Posted On: 07/18/2018 5:20:10 PM
Post# of 53
Avatar
Posted By: NetworkNewsWire
NetworkNewsBreaks – Zenosense, Inc.’s (ZENO) MIDS Cardiac Device Demonstrates Testing Potential

Through a joint-venture ownership in MIDS Medical Ltd., Zenosense (OTC: ZENO) is developing MIDS Cardiac™, a rapid cardiac diagnostic device. An article discussing the device reads: “In the new testing, the joint venture aimed to magnetically detect assay beads below the 200,000 level in order to support a finding that the technology could be effective in a high-sensitivity troponin test. Previously, the technology had detected down to around 100,000 beads; the new testing brings this down to around the 50,000-bead level, indicating that it is well within the necessary level of detection required for a high-sensitivity assay (http://nnw.fm/MlnX9). The new testing used extensively improved core sensor electronics to deliver the near-doubling of the previously obtained sensitivity level.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site